Cipla | CIPLA - Pre Tax Profit

Stock Price
1,421.30
Daily Change
-4.90 -0.34%
Monthly
15.60%
Yearly
-2.28%
Q2 Forecast
1,401.45

Cipla reported INR7.49B in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Cipla INR 7.49B 4.2B Mar/2026
Dr.Reddys Laboratories INR 4.58B 11.09B Mar/2026
Esperion Therapeutics USD 63.67M 95M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
TherapeuticsMD USD -1.05M 241K Jun/2024
UPL INR 7.27B 850M Dec/2025